A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer
Clinical trial NCT05080842 · TERMINATED
Trial details
- NCT number
- NCT05080842
- Sponsor
- Accutar Biotechnology Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-12
- Primary completion
- 2024-04-04
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.